Detalhe da pesquisa
1.
Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
J Virol
; 92(4)2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212932
2.
Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.
Int J Cancer
; 132(3): E139-48, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22961598
3.
Discovering functional gene expression patterns in the metabolic network of Escherichia coli with wavelets transforms.
BMC Bioinformatics
; 7: 119, 2006 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-16524469
4.
Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 Vaccine.
Cancer Prev Res (Phila)
; 8(10): 932-41, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26170394
5.
Development of neutralizing monoclonal antibodies for oncogenic human papillomavirus types 31, 33, 45, 52, and 58.
Clin Vaccine Immunol
; 21(4): 587-93, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24574536
6.
A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses.
Vaccine
; 32(22): 2610-7, 2014 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24662712
7.
Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.
Vaccine
; 32(44): 5880-7, 2014 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25148777
8.
A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.
Sci Rep
; 4: 4729, 2014 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24751665
9.
Influence of oxidation and multimerization on the immunogenicity of a thioredoxin-l2 prophylactic papillomavirus vaccine.
Clin Vaccine Immunol
; 20(7): 1061-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23677323
10.
High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses.
PLoS One
; 8(10): e75677, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24124504
11.
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate.
PLoS One
; 7(6): e39741, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22761884
12.
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.
Virology
; 409(2): 348-59, 2011 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21074234